跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,506 条关于
“ENTR-601-51”
全部
9,506
临床试验
3,867
药物
3,989
机构
109
资讯
1,541
8个月前
Entrada Therapeutics Advances RNA-Based Pipeline with First Ocular Candidate for Usher Syndrome
去年
Entrada Therapeutics Advances DMD Treatment: UK MHRA Approves Phase I/II Trial for Novel Exon-Skipping Therapy
去年
Phase 1 Trial Shows Promise for PSCA-Targeted BPX-601 CAR T-Cell Therapy in Pancreatic and Prostate Cancers
去年
Dyne's DYNE-251 Shows "Unprecedented" Functional Improvements in Duchenne Muscular Dystrophy Trial
去年
Error parsing response
去年
Corbus Pharmaceuticals Doses First Patient in Phase 1 Trial of CRB-601 for Advanced Solid Tumors
2年前
Terns Pharmaceuticals' Oral GLP-1 Agonist TERN-601 Shows Promise in Phase 1 Obesity Trial
去年
Marker Therapeutics Reports Positive Clinical Outcomes for MT-601 in Lymphoma Patients
去年
Marker Therapeutics' MT-601 Shows 78% Response Rate in Refractory Lymphoma Patients
去年
Terns Pharmaceuticals Advances CML Drug TERN-701 and Obesity Treatment TERN-601 in Clinical Trials
第 1 页,共 155 页
上一页
下一页